With effective date January 1st 2013, SCOR has entered into a VIF (Value of In-Force) monetization transaction with BBVA Seguros, a Spanish leading insurance company, to reinsure a whole block of life risk insurance p
With effective date January 1st 2013, SCOR has entered into a VIF (Value of In-Force) monetization transaction with BBVA Seguros, a Spanish leading insurance company, to reinsure a whole block of life risk insurance p
PDF File
PDF File
PDF File
PDF File
PDF File
Colorectal cancer is, with breast, lung and prostate cancer, the most common type of malignant tumour.
Colorectal cancer is, with breast, lung and prostate cancer, the most common type of malignant tumour.
SCOR announced the launch of the “SCOR Corporate Foundation for Science” today.
Each year, in various different European countries, SCOR rewards the best academic work in the field of actuarial science with prizes.
At its annual Investors’ Day being held today in Paris, SCOR presents updated information and analyses demonstrating that the Group is consistently delivering on its promises and is in a perfect position to seize new
